New hope for advanced cancer? early trial of WJB001 begins

NCT ID NCT05773820

Recruiting now Disease control Sponsor: Wigen Biomedicine Technology (Shanghai) Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early-phase study tests an experimental drug called WJB001 in people with advanced solid tumors who have no standard treatment options left. The trial has three parts: first, finding a safe dose; second, checking how well that dose works; and third, testing it in specific tumor types. About 210 participants will take WJB001 capsules daily in cycles, with researchers closely monitoring safety and any tumor shrinkage.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: WJB001 capsules
What this could lead to: If this trial succeeds, it could point toward a new treatment option for people with advanced solid tumors who have run out of standard therapies.
What could go wrong: This is a very early Phase I/II trial with only 210 participants. The drug may not work as hoped, and side effects could be serious. Success in this small group may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADVANCED SOLID TUMORS

Contacts and locations

Locations

Cancer Hospital Chinese Academy of Medical Sciences
RECRUITING

Beijing, Beijing Municipality, 100021, China
Fujian Cancer Hospital
RECRUITING

Fuzhou, Fujian, 350000, China
Fuxin People's Hospital (Fuxin Women and Children's Medical Center)
NOT_YET_RECRUITING

Fuxin, Liaoning, 123000, China
Henan Cancer Hospital
RECRUITING

Henan, Zhenzhou, 450000, China
Hunan Cancer Hospital
RECRUITING

Changsha, Hunan, 410000, China
Liaoning Cancer Hospital
RECRUITING

Shenyang, Liaoning, 110000, China
Shanxi Cancer Hospital
RECRUITING

Taiyuan, Shanxi, 030000, China
Sun Yat-sen University Cancer Center
RECRUITING

Guangzhou, Guangdong, 510000, China
The First Affiliated Hospital of Xi 'an Jiaotong University
RECRUITING

Xi’an, Shanxi, 710061, China
Tumor Hospital Affiliated to Guangxi Medical University
RECRUITING

Nanning, Guangxi, 530000, China
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
RECRUITING

Wuhan, Hubei, 430023, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.